Showing results (211-220 of 634) with videos related to

Sort By:
Pageof 64
Human Pathology|August 30, 2006
Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70)Ulrika Schade, Oliver Bock, Sylke Vornhusen, et al.
Cancer Science|June 25, 2009
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancerMatthias Christgen, Henriette Christgen, Charlotte Heil, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 16, 2005
Quantitative mRNA expression analysis of co-stimulatory molecules in sequential biopsies from heart allograftsFatma Akdere, Oliver Bock, Ulrich Lehmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2017
Estrogen receptor (ESR1) mutation in bone metastases from breast cancerStephan Bartels, Matthias Christgen, Angelina Luft, et al.
Transplantation|December 1, 2007
Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allograftsDanny Jonigk, Ulrich Lehmann, Stephan Stuht, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2024
Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patientsMaria Sandbothe, Britta Hasemeier, Elisa Schipper, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2018
Activating human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancerMatthias Christgen, Stephan Bartels, Angelina Luft, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
European Journal of Haematology|January 18, 2021
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progressionStephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2021
Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primaryMaria Pouyiourou, Timothy Wohlfromm, Bianca Kraft, et al.
Pageof 64